Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With Teva out, OncoGenex shrinks its PhIII lung cancer study
With Teva out, OncoGenex shrinks its PhIII lung cancer study
With Teva out, OncoGenex shrinks its PhIII lung cancer study
Submitted by
admin
on April 30, 2015 - 10:45am
Source:
Fierce Biotech
News Tags:
Teva Pharmaceutical
OncoGenex
non-small cell lung cancer
custirsen
Headline:
With Teva out, OncoGenex shrinks its PhIII lung cancer study
Do Not Allow Advertisers to Use My Personal information
